Elder Pharmaceuticals (USA) Inc.
GPTKB entity
Properties (49)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:XYZ_Pharma
|
| gptkbp:awards |
Innovation Award 2021
Best_Pharma_Company_2020 |
| gptkbp:CEO |
gptkb:John_Doe
|
| gptkbp:clinicalTrials |
Phase 1
Phase 2 Phase 3 |
| gptkbp:collaborations |
gptkb:University_of_Health_Sciences
gptkb:Global_Pharma_Alliance Local Health Organizations |
| gptkbp:community_involvement |
Volunteer Work
Charity Donations Health Awareness Programs |
| gptkbp:employees |
500
|
| gptkbp:founded |
1993
|
| gptkbp:headquarters |
gptkb:New_Jersey
|
| https://www.w3.org/2000/01/rdf-schema#label |
Elder Pharmaceuticals (USA) Inc.
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:investmentFocus |
$20 million in R&D
$10 million in infrastructure $5 million in marketing |
| gptkbp:market |
gptkb:Asia
gptkb:North_America Europe |
| gptkbp:partnerships |
gptkb:ABC_Biotech
|
| gptkbp:patentCitation |
50+
|
| gptkbp:products |
Over-the-Counter Medications
Prescription Drugs |
| gptkbp:regulatoryCompliance |
gptkb:FDA
EMA |
| gptkbp:research_focus |
Cardiology
Neurology Infectious Diseases Chronic Diseases |
| gptkbp:revenue |
$100 million
|
| gptkbp:services |
Manufacturing
Marketing Research_and_Development |
| gptkbp:subsidiary |
Elder_Biotech
Elder_Generics Elder_Research |
| gptkbp:sustainability_initiatives |
Green Manufacturing
Energy Efficiency Projects Waste Reduction Programs |
| gptkbp:trademark |
ElderHealth
ElderMed ElderCare |
| gptkbp:website |
www.elderpharma.com
|